Accurate Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-12-2024
- Paid Up Capital ₹ 3.75 M
as on 16-12-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.36 Cr
as on 16-12-2024
- Revenue 31.54%
(FY 2022)
- Profit 229.28%
(FY 2022)
- Ebitda 326.98%
(FY 2022)
- Net Worth 9.25%
(FY 2022)
- Total Assets 13.02%
(FY 2022)
About Accurate Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.75 M.
The company has closed loans amounting to ₹3.36 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanjay Gupte, Asmita Gupte, Arti Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110PN1996PTC098387
- Company No.
098387
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 1996
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Accurate Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Gupte  | Director | 25-Mar-1996 | Current |
| Asmita Gupte | Director | 25-Mar-1996 | Current |
| Arti Shah | Director | 25-Mar-2003 | Current |
| Anisha Gupte | Director | 12-Dec-2012 | Current |
Financial Performance of Accurate Diagnostics.
Accurate Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.54% increase. The company also saw a substantial improvement in profitability, with a 229.28% increase in profit. The company's net worth moved up by a moderate rise of 9.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accurate Diagnostics?
Unlock access to Accurate Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Greenarray Genomic Research & Solutions Private LimitedActive 1 year 5 months
Sanjay Gupte, Asmita Gupte and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bhagini Nivedita Sahakari Bank Limited Creation Date: 03 Nov 2006 | ₹1.50 Cr | Satisfied |
Punjab National Bank Creation Date: 28 Jun 2004 | ₹4.10 M | Satisfied |
Punjab National Bank Creation Date: 28 Jun 2004 | ₹1.45 Cr | Satisfied |
How Many Employees Work at Accurate Diagnostics?
Unlock and access historical data on people associated with Accurate Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accurate Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accurate Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
